Answers are grounded in this paper and cite their sources.
Acquired haemophilia A (AHA) is a rare condition due to neutralizing antibodies against Factor VIII and can result in severe bleeding manifestations. The association of AHA with bullous pemphigoid (BP) is rare, most frequently observed in the elderly, and has been attributed to cross‐reactive antibodies targeting Factor VIII and BPAG2 protein. The diagnosis of AHA requires specific investigations, and treatment involves urgent haemostasis and intensive immunosuppression. Managing both conditions simultaneously is challenging due to the risk of severe bleeding and treatment‐related complications including infections. Early diagnosis and treatment are crucial to improve outcomes in these patients.
No takes yet. Share an insight, caveat, or question.
Ho et al. (2025) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: